[A case of recurrent colon cancer developed thrombosis in superior mesenteric vein after chemotherapy].
Hiroaki Furuyama, Hiroaki Fuji, Shinya Okumura, Tatsuhito Nishigori, Yoshio Kadokawa, Masato Kondo, Takafumi Machimoto, Yoshito Asao, Tsunehiro Yoshimura
Index: Gan To Kagaku Ryoho. 40(5) , 659-61, (2013)
Full Text: HTML
Abstract
A 48-year-old man was administered bevacizumab+FOLFOX for lymph node recurrence of colon cancer in the abdominal cavity, and developed serious thrombosis of the portal system after 6 courses of the chemotherapy. We discontinued it promptly and anticoagulant therapy with urokinase was started immediately, but a complete dissolution was not achieved. Preservation therapy using anticoagulants for a long duration was effective for controling the of clinical symptom of thrombosis. The result of 6 courses of chemotherapy was CR, and the effect continues today, without further treatment 2 years later.
Related Compounds
Related Articles:
TAp73 promotes cell survival upon genotoxic stress by inhibiting p53 activity.
2014-09-30
[Oncotarget 5(18) , 8107-22, (2014)]
cIEF for rapid pKa determination of small molecules: a proof of concept.
2014-10-15
[Eur. J. Pharm. Sci. 63 , 14-21, (2014)]
Establishment and characterization of cell lines from chromosomal instable colorectal cancer.
2015-01-07
[World J. Gastroenterol. 21(1) , 164-76, (2015)]
[Iran. J. Pharm. Res. 14(2) , 395-405, (2015)]
2015-08-01
[Cancer Sci. 106 , 1000-7, (2015)]